• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • Homepage
  • About Us
  • Advertising
  • Submission Instructions
  • Editorial Calendar
Amstat News

Amstat News

The Membership Magazine of the American Statistical Association

  • Printed Issues
  • Practical Significance Podcast
  • Additional Features
  • Columns
  • Member News
  • Departments
You are here: Home / Member News / Section News / Biopharmaceutical / Biopharmaceutical Report Focuses on Statistical Issues in COVID-19 Trials

Biopharmaceutical Report Focuses on Statistical Issues in COVID-19 Trials

December 1, 2020 Leave a Comment

The Biopharmaceutical Report editorial team invited authors from government, industry, and academia to write articles about their perspectives on the impact of COVID-19 on clinical trials, particularly the statistical issues involved in designing new COVID-19 trials. The 2020 fall issue includes these articles.

Steve Wolf of Duke University, Peter Mesenbrink of Novartis, Herbert Pang of Genentech, and Xiaofei Wang of Duke University report a survey of COVID-19–related clinical trials based on the data extracted from Clinicaltrials.gov as of early October 2020. The article sets the stage for discussion about the status of and possible future design and statistical analysis issues in developing a safe and effective vaccine and treatments for COVID-19.

Zachary McCaw of Google, Lu Tian of Stanford, and Lee-Jen Wei of Harvard summarize recent work about how to quantify treatment effect and competing risk in COVID-19 clinical trials.

Peter Mesenbrink of Novartis shares his experience designing several COVID-19 trials.

Mitchell Thomann, Michael Durante, and Paul Berg of Eli Lilly write about simulation studies they conducted to gain insight into choosing optimal study endpoints in a proof-of-concept trial.

Sheng Feng, Amanda Shield, and Andy Wilson of Parexel contribute a short article about the challenges and possible solutions of conducting real-world evidence studies on COVID-19 treatment.

An article by Yongming Qu and Ilya Lipkovich of Eli Lilly provides a comprehensive review of estimands and estimation of treatment effect of clinical trials during COVID-19 in the context of ICH E9.

In this issue, there is also an interview with Margaret Gamalo, the new editor for the Journal of Biopharmaceutical Statistics, and a summary report from Statistical Methods in Oncology Scientific Working Group on type I error considerations in master protocols.

Filed Under: Biopharmaceutical, Previous Features, Section News Tagged With: ASA, biopharmaceutical, Biopharmaceutical Report, biostatistics, clinical trials, covid-19, covid-19 treatments, covid-19 trials, covid-19 vaccine, data, data science, oncology, section, statistician, statisticians, statistics

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

Search

More to See

A brown-skinned man with short dark hair, glasses, and a short beard in a zip-up sweatshirt

New Member Spotlight: Bilal Shaikh

November 2, 2026 By Meg Ruyle

A dark-skinned man poses in front of two statues

Member Showcase: Arun Chind: An Interdisciplinary Journey Through Statistics, Medicine, Economics, and Law

November 2, 2026 By Meg Ruyle

A white woman with blonde hair wearing a maroon shirt poses outside

ASA Founders Award Recipient Alex Hanlon: A Career Built on Collaboration

November 2, 2026 By Meg Ruyle

A woman with long dark hair wearing glasses smiles

AAAS Mass Media Fellow Lauren Chan: Advancing Evidence-Based Science Through Storytelling

November 2, 2026 By Meg Ruyle

Join SIAM now and get 25% off. SIAM membership includes thousands of app;ied mathematicians and computational and data scientists working in academia, industry, government, and labs. Get 25% off regular membership prices when you join by Dec. 31, 2026 and enter promo code MBNW27AT
Thank you Stata for sponsoring the November issue of practical significance.
Sign up to become a MentorLink Mentor. Through MentorLink, ASA members can connect with mentees looking for guidance, perspecitve, and support as they navigate their careers.

ASA HOME

American Statistical Association

Communications from the Executive Director

ASA Leader Hub

ASA Career Connect

STAFF LIST

Kim Gilliam
Naomi Friedman
Amanda Malloy
Kristin Mohebbi

Archives

Categories

Footer

Editorial Staff

Managing Editor
Megan Murphy

Graphic Designers / Production Coordinators
Olivia Brown
Meg Ruyle

Communications Strategist
Val Nirala

Advertising Manager
Christina Bonner

Contributing Staff Members
Kim Gilliam

American Statistical Association
277 South Washington Street, Suite 370
Alexandria, VA 22314-3646
Phone: (703) 302-1857

 

Copyright © 2026 · Magazine Pro on Genesis Framework · WordPress · Log in